Sun Pharma Q2 results: Consolidated profit beats estimates, rises 5%

Pharma major Sun Pharma posted a 5 percent year-on-year (YoY) rise in its consolidated net profit…

JP Morgan upgrades India to ‘overweight’; advises buying on dips

After a 7 percent drop in the Indian market from its peak hit in mid-September, global…

Sun Pharma to buy 100% stake in Taro in all-cash deal; check details

Through a reverse triangular merger, Sun Pharmaceutical Industries has proposed to buy out all of Taro…

Sun Pharma to benefit from strong outlook for its specialty portfolio

MUMBAI: Shares of Sun Pharmaceutical Industries Ltd are hovering near the 52-week high hit in early…

Sun Pharma cheers up Q2 Street

New Delhi Sun Pharmaceutical Industries Ltd.’s second-quarter earnings were driven by growth in the specialty business…

Sun Pharma gets observation from USFDA for Halol plant, stocks under pressure

Sun Pharma today said the US health regulator has issued ‘Form 483’ with ten observations after…

Sun Pharma’s two US arms reach settlement over antitrust lawsuit

Sun Pharma Limited today informed stock exchanges that two of its US-based subsidiaries have signed settlement…